MedPath

Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China

Completed
Conditions
Non-valvular Atrial Fibrillation
Interventions
Registration Number
NCT04747496
Lead Sponsor
Daiichi Sankyo
Brief Summary

The safety of edoxaban treatment will be examined using real-world clinical evidence from adult patients with non-valvular atrial fibrillation (NVAF) indications in routine clinical practice.

Detailed Description

This non-interventional, observational study will evaluate the safety of edoxaban treatment in adult patients with NVAF indications with one or more risk factors.

The primary objective of the study is to collect and evaluate safety data up to 2 years in a real-world setting in relation to adverse event onset (related to edoxaban treatment), duration, severity, and outcome.

The secondary objective will evaluate the effect of edoxaban treatment on stroke (ischemic and hemorrhagic), systemic embolic event (SEE), transient ischemic attack (TIA), major adverse cardiovascular events (MACE), venous thromboembolism (VTE), acute coronary syndrome (ACS), hospitalization related to cardiovascular condition, extent of exposure and compliance to edoxaban therapy, and rate and reasons of permanent discontinuation of edoxaban therapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5000
Inclusion Criteria
  • Written, informed consent
  • NVAF-patients treated with edoxaban according to packaging information (i.e., for NVAF adult patients with one or more risk factors (such as history of congestive heart failure, hypertension, age β‰₯75 years old, diabetes, prior stroke or TIA) in prevention of stroke and systemic circulation embolism)
  • Not participating in any interventional study at the same time
Exclusion Criteria
  • Not applicable

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
NVAF patientsEdoxabanNVAF adult patients with one or more risk factors treated with edoxaban.
Primary Outcome Measures
NameTimeMethod
Incidence (including 95% confidence intervals) of clinically related non-major bleeding events following edoxaban treatmentBaseline up to 2 years post treatment
Incidence (including 95% confidence intervals) of adverse events/adverse drug reactions following edoxaban treatmentBaseline up to 2 years post treatment
Incidence (including 95% confidence intervals) of major bleeding events following edoxaban treatmentBaseline up to 2 years post treatment
Incidence (including 95% confidence intervals) of mortality (cardiovascular and all-cause) following edoxaban treatmentBaseline up to 2 years post treatment
Secondary Outcome Measures
NameTimeMethod
Proportion of participants who discontinued edoxaban treatment in NVAF patientsBaseline up to 2 years post treatment
Incidence (including 95% confidence intervals) of major adverse cardiovascular events (MACE) following edoxaban treatmentBaseline up to 2 years post treatment
Duration of exposure to edoxaban treatment in NVAF patientsBaseline up to 2 years post treatment
Incidence (including 95% confidence intervals) of stroke (ischemic and hemorrhagic) following edoxaban treatmentBaseline up to 2 years post treatment
Incidence (including 95% confidence intervals) of systemic embolic event (SEE) following edoxaban treatmentBaseline up to 2 years post treatment
Incidence (including 95% confidence intervals) of venous thromboembolism (VTE) following edoxaban treatmentBaseline up to 2 years post treatment
Number of interventions related to atrial fibrillation/edoxaban in NVAF patientsBaseline up to 2 years post treatment
Incidence (including 95% confidence intervals) of hospitalizations related to cardiovascular condition following edoxaban treatmentBaseline up to 2 years post treatment
Incidence (including 95% confidence intervals) of transient ischemic attack (TIA) following edoxaban treatmentBaseline up to 2 years post treatment
Incidence (including 95% confidence intervals) of acute coronary syndrome (ACS) following edoxaban treatmentBaseline up to 2 years post treatment
Compliance rate of edoxaban treatment in NVAF patientsBaseline up to 2 years post treatment

Trial Locations

Locations (96)

The First Affiliated Hospital of Guangzhou Medical University

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

Changzhou No.2 People'S Hospital

πŸ‡¨πŸ‡³

Changzhou, Jiangsu, China

Taiyuan Central Hospital of Shanxi Medical University

πŸ‡¨πŸ‡³

Taiyuan, Shanxi, China

West China Hospital, Sichuan University

πŸ‡¨πŸ‡³

Chengdu, Sichuan, China

The First Affiliated Hospital of Wenzhou Medical University

πŸ‡¨πŸ‡³

Wenzhou, Zhejiang, China

Dongfeng General Hospital of Chinese Medicine

πŸ‡¨πŸ‡³

Shiyan, Hubei, China

Aviation General Hospital of China Medical University

πŸ‡¨πŸ‡³

Beijing, Chaoyang District, China

Beijing Tsinghua Changgung Hospital Affiliated Hospital of Tsinghua University

πŸ‡¨πŸ‡³

Beijing, Changping District, China

Beijing Anzhen Hospital, Capital Medical University

πŸ‡¨πŸ‡³

Beijing, Chaoyang District, China

Beijing Chao-Yang Hospital Capital Medical University

πŸ‡¨πŸ‡³

Beijing, China

Beijing Hospital

πŸ‡¨πŸ‡³

Beijing, Dongcheng District, China

Beijing Tongren Hospital,Cmu

πŸ‡¨πŸ‡³

Beijing, Dongcheng District, China

The First Hospital of Lanzhou University

πŸ‡¨πŸ‡³

Lanzhou, Gansu, China

Guangdong Second Provincial General Hospital

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

Guangzhou First People'S Hospital

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

Guangzhou Panyu Central Hospital

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

The First Affiliated Hospital of Jinan University

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

The First Affiliated Hospital, Sun Yat-Sen University

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

The Second Affiliated Hospital of Guangzhou Medical University

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

The First People'S Hospital of Nanning

πŸ‡¨πŸ‡³

Nanjing, Guangxi Province, China

The Third People'S Hospital of Nanning

πŸ‡¨πŸ‡³

Nanning, Guangxi Province, China

Zhujiang Hospital of Southern Medical University

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

Heilongjiang Provincial Hospital

πŸ‡¨πŸ‡³

Harbin, Heilongjiang, China

Kaifeng Central Hospital

πŸ‡¨πŸ‡³

Kaifeng, Henan, China

The Third Affiliated Hospital of Xinxiang Medical University

πŸ‡¨πŸ‡³

Xinxiang, Henan, China

Xinxiang Central Hospital

πŸ‡¨πŸ‡³

Xinxiang, Henan, China

The Fifth Affiliated Hospital of Zhengzhou University

πŸ‡¨πŸ‡³

Zhengzhou, Henan, China

The Second Affiliated Hospital of Zhengzhou University

πŸ‡¨πŸ‡³

Zhengzhou, Henan, China

Shanghai Ninth People'S Hospital,Shanghai Jiaotong University School of Medicine

πŸ‡¨πŸ‡³

Shanghai, Huangpu District, China

Tianjin Medical University General Hospital

πŸ‡¨πŸ‡³

Tianjin, Heping District, China

The Second Hospital of Tianjin Medical University

πŸ‡¨πŸ‡³

Tianjin, Hexi District, China

Hebei Petro China Center Hospital

πŸ‡¨πŸ‡³

Langfang, Hubei, China

Renmin Hospital of Wuhan University Hubei General Hospital

πŸ‡¨πŸ‡³

Wuhan, Hubei, China

The Central Hospital of Wuhan

πŸ‡¨πŸ‡³

Wuhan, Hubei, China

Tongji Hospital,Tongji Medical College Huazhong University of Science & Technology

πŸ‡¨πŸ‡³

Wuhan, Hubei, China

Union Hospital Affiliated With Tongji Medical College of Huazhong University of Science and Technology

πŸ‡¨πŸ‡³

Wuhan, Hubei, China

Wuhan Puai Hospital

πŸ‡¨πŸ‡³

Wuhan, Hubei, China

Wuhan Third Hospital

πŸ‡¨πŸ‡³

Wuhan, Hubei, China

Zhongnan Hospital of Wuhan University

πŸ‡¨πŸ‡³

Wuhan, Hubei, China

Changsha Central Hospital

πŸ‡¨πŸ‡³

Changsha, Hunan, China

The Fourth Hospital of Changsha

πŸ‡¨πŸ‡³

Changsha, Hunan, China

The First Hospital of Changsha

πŸ‡¨πŸ‡³

Changsha, Hunan, China

Hunan Provincial People'S Hospital

πŸ‡¨πŸ‡³

Changsha, Hunan, China

The Third Xiangya Hospital of Central South University

πŸ‡¨πŸ‡³

Changsha, Hunan, China

Xiangtan Central Hospital

πŸ‡¨πŸ‡³

Xiangtan, Hunan, China

The First People'S Hospital of Kunshan

πŸ‡¨πŸ‡³

Kunshan, Jiangsu, China

Jiangyin People'S Hospital

πŸ‡¨πŸ‡³

Jiangyin, Jiangsu, China

The Second Affiliated Hospital of Nanjing Medical University

πŸ‡¨πŸ‡³

Nanjing, Jiangsu, China

Jiangxi Provincial People'S Hospital

πŸ‡¨πŸ‡³

Nanchang, Jiangsu, China

Nanjing Jiangning Hospital

πŸ‡¨πŸ‡³

Nanjing, Jiangsu, China

The Second People'S Hospital of Suzhou

πŸ‡¨πŸ‡³

Suzhou, Jiangsu, China

Affiliated Hospital of Jiangnan University

πŸ‡¨πŸ‡³

Wuxi, Jiangsu, China

The Affiliated Hospital of Xuzhou Medical University

πŸ‡¨πŸ‡³

Xuzhou, Jiangsu, China

Wuxi People'S Hospital

πŸ‡¨πŸ‡³

Wuxi, Jiangsu, China

Xuzhou Central Hospital

πŸ‡¨πŸ‡³

Xuzhou, Jiangsu, China

The Fourth Hospital of Jilin University

πŸ‡¨πŸ‡³

Changchun, Jilin, China

Jilin Province People'S Hospital

πŸ‡¨πŸ‡³

Changchun, Jilin, China

The First Affiliated Hospital of Dalian Medical University

πŸ‡¨πŸ‡³

Dalian, Liaoning, China

The Second Hospital of Jilin University

πŸ‡¨πŸ‡³

Changchun, Jilin, China

China Shenyang Chest Hospital

πŸ‡¨πŸ‡³

Shenyang, Liaoning, China

Beijing Miyun District Hospital

πŸ‡¨πŸ‡³

Beijing, Minyun District, China

The Second Affiliated Hospital of Shenyang Medical College

πŸ‡¨πŸ‡³

Shenyang, Liaoning, China

Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University

πŸ‡¨πŸ‡³

Shanghai, Qingpu District, China

Shanghai East Hospital,Tongji University

πŸ‡¨πŸ‡³

Shanghai, Pudong New Area, China

Affiliated Hospital of Weifang Medical University

πŸ‡¨πŸ‡³

Weifang, Shandong, China

The Fifth People'S Hospital of Jinan

πŸ‡¨πŸ‡³

Jinan, Shandong, China

Hangzhou Third Hospital

πŸ‡¨πŸ‡³

Hangzhou, Shangcheng District, China

Heping Hospital Affiliated to Changzhi Medical College

πŸ‡¨πŸ‡³

Changzhi, Shanxi, China

Shanxi Bethune Hospital

πŸ‡¨πŸ‡³

Taiyuan, Shanxi, China

Shanxi Cardiovascular Hospital

πŸ‡¨πŸ‡³

Taiyuan, Shanxi, China

Shanxi Provincial People'S Hospital

πŸ‡¨πŸ‡³

Taiyuan, Shanxi, China

Beijing Chest Hospital, Capital Medical University

πŸ‡¨πŸ‡³

Beijing, Tongzhou District, China

Peking Union Medical College Hospital

πŸ‡¨πŸ‡³

Beijing, Xicheng District, China

The First Affiliated Hospital of Xinjiang Medical University

πŸ‡¨πŸ‡³

Ürümqi, Xinjiang Province, China

Xuanwu Hospital Capital Medical University

πŸ‡¨πŸ‡³

Beijing, Xuanwu District, China

Shanghai Yangpu East Hospital

πŸ‡¨πŸ‡³

Shanghai, Yangpu District, China

Longhua Hospital Shanghai University of Traditional Chinese Medicine

πŸ‡¨πŸ‡³

Shanghai, Xuhui District, China

The First Hospital of Kunming

πŸ‡¨πŸ‡³

Kunming, Yunnan, China

The Second Affiliated Hospital of Chongqing Medical University

πŸ‡¨πŸ‡³

Chongqing, Yuzhong District, China

Chongqing General Hospital

πŸ‡¨πŸ‡³

Chongqing, Yuzhong District, China

The First Affiliated Hospital of Chongqing Medical University

πŸ‡¨πŸ‡³

Chongqing, Yuzhong District, China

Zhejiang Greentown Cardiovascular Hospital

πŸ‡¨πŸ‡³

Hangzhou, Zhejiang, China

Zhejiang Provincial Hospital of Chinese Medicine

πŸ‡¨πŸ‡³

Hangzhou, Zhejiang, China

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

πŸ‡¨πŸ‡³

Hangzhou, Zhejiang, China

Zhejiang Hospital

πŸ‡¨πŸ‡³

Hangzhou, Zhejiang, China

Zhejiang Provincial People'S Hospital

πŸ‡¨πŸ‡³

Hangzhou, Zhejiang, China

The First Hospital of Jiaxing

πŸ‡¨πŸ‡³

Jiaxing, Zhejiang, China

The Second Hospital of Jiaxing

πŸ‡¨πŸ‡³

Jiaxing, Zhejiang, China

Ningbo First Hospital

πŸ‡¨πŸ‡³

Ningbo, Zhejiang, China

Wenzhou Central Hospital

πŸ‡¨πŸ‡³

Wenzhou, Zhejiang, China

Wenzhou Hospital of Traditional Chinese Medicine

πŸ‡¨πŸ‡³

Wenzhou, Zhejiang, China

Tsinghua University Affiliated Beijing Tsinghua Changgeng Hospital

πŸ‡¨πŸ‡³

Beijing, China

Wenzhou People'S Hospital

πŸ‡¨πŸ‡³

Wenzhou, Zhejiang, China

The Fourth Hospital of Changhsa

πŸ‡¨πŸ‡³

Changsha, China

Peking University First Hospital

πŸ‡¨πŸ‡³

Beijing, Xicheng District, China

Β© Copyright 2025. All Rights Reserved by MedPath